VOLUME 62 2001 NUMBER 8
CME Pretest 588
CME Posttest 663
Commentary
589 Grow the Market. Alan J. Gelenberg
[PDF]
Brainstorms
590 Gut Feelings About Irritable Bowel Syndrome. Stephen M.
Stahl
[PDF]
Original Articles
592 Venlafaxine in the Treatment of Postpartum Depression. Lee
S. Cohen, Adele C. Viguera, Suzanne M. Bouffard, Ruta M. Nonacs,
Cassandra Morabito, Mary H. Collins, and J. Stuart Ablon
[Abstract]
[PDF]
597 A Double-Blind Randomized Comparison of Nortriptyline Plus
Perphenazine Versus Nortriptyline Plus Placebo in the Treatment
of Psychotic Depression in Late Life. Benoit H. Mulsant,
Robert A. Sweet, Jules Rosen, Bruce G. Pollock, George S.
Zubenko, Tracy Flynn, Amy E. Begley, Sati Mazumdar, and Charles
F. Reynolds III
[Abstract]
[PDF]
605 Risperidone Added to Clozapine: Impact on Serum Prolactin
Levels. David C. Henderson, Donald C. Goff, Christine E.
Connolly, Christina P. Borba, and Doug Hayden
[Abstract]
[PDF]
609 Why Do Young Women Diet? The Roles of Body Fat, Body
Perception, and Body Ideal. [CME] Amanda
J. Gruber, Harrison G. Pope, Jr., Justine K. Lalonde, and James
I. Hudson
[Abstract]
[PDF]
612 The Impact of Antidepressant Discontinuation Versus
Antidepressant Continuation on 1-Year Risk for Relapse of Bipolar
Depression: A Retrospective Chart Review. Lori Altshuler,
Lindsay Kiriakos, Jeff Calcagno, Robyn Goodman, Michael Gitlin,
Mark Frye, and Jim Mintz
[Abstract]
[PDF]
617 Virtual Reality Exposure Therapy for Vietnam Veterans With
Posttraumatic Stress Disorder. Barbara O. Rothbaum, Larry F.
Hodges, David Ready, Ken Graap, and Renato D. Alarcon
[Abstract]
[PDF]
623 Efficacy and Safety of Risperidone in the Treatment of
Schizoaffective Disorder: Initial Results From a Large,
Multicenter Surveillance Study. Eduard Vieta, Marisa Herraiz,
Antonio Fernandez, Cristobal Gasto, Antonio Benabarre, Francesc
Colom, Anabel Martinez-Aran, Maria Reinares for the Group for the
Study of Risperidone in Affective Disorders (GSRAD)
[Abstract]
[PDF]
631 A 1-Year Follow-Up Study of Behavioral and Psychological
Symptoms in Dementia Among People in Care Environments. [CME] Clive G. Ballard, Marisa
Margallo-Lana, Jane Fossey, Katharina Reichelt, Pat Myint, Dawn
Potkins, and John O'Brien
[Abstract]
[PDF]
637 Patterns of Temperament and Character in Subjects With
Obsessive-Compulsive Disorder. In Kyoon Lyoo, Dong Woo Lee,
Yeon Su Kim, Seog Weon Kong, and Jun Soo Kwon
[Abstract]
[PDF]
642 Effects of Fluvoxamine and Paroxetine on Sleep Structure
in Normal Subjects: A Home-Based Nightcap Evaluation During Drug
Administration and Withdrawal. Rosalia Silvestri, Edward F.
Pace-Schott, Tamara Gersh, Robert Stickgold, Carl Salzman, and J.
Allan Hobson
[Abstract]
[PDF]
Letters To the Editor
653 Auditory Hallucinations Associated With Topiramate. Scott
C. Matthews and Brian P. Miller
[PDF]
653 Metformin in Obesity Associated With Antipsychotic Drug
Administration: A Pilot Study. Trino Baptista, Luis Hernandez,
Lisette Alvarez Prieto, Evelyn Cubillan Boyero, and Soaira de
Mendoza
[PDF]
655 Reboxetine-Induced Hypomania. Eduard Vieta, Francesc
Colom, Anabel Martinez-Aran, Maria Reinares, Antonio Benabarre,
Barbara Corbella, and Cristobal Gasto
[PDF]
656 Tiagabine Improves Panic and Agoraphobia in Panic Disorder
Patients. Peter Zwanzger, Thomas C. Baghai, Cornelius Schule,
Christo Minov, Frank Padberg, Hans-Jurgen Moller, and Rainer
Rupprecht
[PDF]
657 Switching From Benzodiazepines to Buspirone Using a
Tapered Overlap Method in Generalized Anxiety Disorder. Mihaly
Arato
[PDF]
658 Corrections. Doghramji PP. Detection of insomnia in
primary care (J Clin Psychiatry 2001;62[suppl 10]:1826); Pollack
MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB,
Iyengar MK. Paroxetine in the treatment of generalized
anxiety disorder: results of a placebo-controlled,
flexible-dosage trial (J Clin Psychiatry 2001;62:350357)
[PDF]
Book Reviews 659
NOW@Psychiatrist.com 665
Information for Authors
see July 2001, pages 579-581 or our Web site at www.psychiatrist.com/author.htm